container

New Advances in Insulin Injection Research Influences Patient Adherence

US Endocrinology, the peer-reviewed journal, publishes article that looks at Adherence to insulin therapy which is estimated at 62–64% despite research indicating that good glycemic control improves patient outcomes.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Insulin formulations and injection devices have improved dramatically since the first insulin injection was given in 1922.

(PRWEB UK) 3 June 2014

US Endocrinology, the peer-reviewed journal, publishes article that looks at Adherence to insulin therapy which is estimated at 62–64% despite research indicating that good glycemic control improves patient outcomes.

Insulin formulations and injection devices have improved dramatically since the first insulin injection was given in 1922. Adherence to insulin therapy, however, is estimated at 62–64% despite research indicating that good glycemic control improves patient outcomes. The challenge is to improve the rates of adherence and to intensify or progress insulin therapy as needed. Changes in insulin delivery devices, especially innovations in needle technology in combination with education and support, have the potential to improve the comfort of insulin injections and encourage patients to adhere to their insulin regimens.

To continue reading this peer-reviewed article in full for free please go to: http://www.touchendocrinology.com/articles/advances-insulin-injection-research-influences-patient-adherence.

NOTE TO EDITORS
touchENDOCRINOLOGY (a division of Touch Medical Media) provides independent, cutting-edge, peer-reviewed content from world renowned physicians, designed to lead the debate on health and to engage, inform, and support physicians in improving patient outcomes globally.

touchENDOCRINOLOGY.com provides an international platform for peer-reviewed content from industry-leading journals alongside other carefully selected sources and aims to support physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity within the field of diabetes.

Our portfolio of peer-reviewed journals, European Endocrinology and US Endocrinology comprise of concise review articles which are designed to keep busy physicians up-to-date with the latest developments in their field and serve as a key reference resource for the international diabetes community.

http://www.touchendocrinology.com


Contact